🚨 Medication Recall Alert:

Sulfamethoxazole/Trimethoprim Tablets Recalled Due to Contamination Risk

Posted June 17, 2025

Amneal Pharmaceuticals has issued a nationwide recall of three lots of Sulfamethoxazole/Trimethoprim Tablets, USP (400 mg/80 mg), due to the discovery of black spots on some tablets, linked to microbial contamination with Aspergillus, a type of fungus that can cause serious or life-threatening infections, especially in immunocompromised individuals.

⚠️ Recalled Lots:

• AM241019

• AM241019A

• AM241020

All affected tablets are the 400 mg/80 mg dosage and have an expiration date of June 2027.

📦 Distribution Window:

These lots were distributed across the U.S. between December 4, 2024, and May 15, 2025, to wholesalers, pharmacies, clinics, and distributors. Tablets obtained before December 4, 2024, are not affected.

💊 About the Medication:

Sulfamethoxazole/Trimethoprim is commonly used to treat:

• Urinary tract infections (UTIs)

• Middle-ear infections in children

• Pneumonia and sepsis

• Traveler’s diarrhea

✅ What to Do:

• Check your prescription bottle for the lot number.

• If you have medication from the affected lots, stop using it immediately.

• Contact Amneal Pharmaceuticals for return and reimbursement instructions:

  
  

  • 📞 833‑582‑0812 (Monday–Friday, 8 am–5 pm ET)

  • 📧 sulfamethoxazole-trimethoprim-recall@amneal.com

• 
  

As of now, no adverse health events have been reported, but caution is strongly advised.

If you have any questions or concerns about your medication, always consult your pharmacist or healthcare provider. Stay informed and stay safe.